Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations.

Standard

Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations. / Andresen, Hilke; Sprys, N; Schmoldt, Achim; Müller, Alexander; Iwersen-Bergmann, Stefanie.

in: FORENSIC SCI INT, Jahrgang 200, Nr. 1-3, 1-3, 2010, S. 93-99.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{36dea874469f4174852d0d48e7746241,
title = "Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations.",
abstract = "Besides the use of Gamma-Hydroxybutyrate (GHB) as a recreational drug, use of GHB as an agent in drug-facilitated crime should also be considered. In these cases, there is often a delay of several hours from the incident to collection of the samples. As GHB has a very short plasma half-life, the window of detection is small and in the majority of these specimens, levels of GHB are low. Because GHB is naturally occurring in humans, discrimination between endogenous and exogenous GHB is complicated, particularly in those samples with low concentrations. In this study, endogenous GHB levels of 50 serum and 50 urine samples were determined by GC-MS after conversion to trimethyl-silyl-derivatives. Concentrations in serum ranged from 0.62 to 3.24 mg/L (mean=1.14 mg/L; median=0.97 mg/L) and from 0.64 to 4.20mg/L (mean=1.21 mg/L; median=0.96 mg/L) in urine. Based on this substantial data, the current suggested lower cut-off of 4 mg/L in ante mortem serum samples could be confirmed. For urine, we propose the lower cut-off of 6 mg/L instead of 10mg/L to avoid false negative interpretation.",
author = "Hilke Andresen and N Sprys and Achim Schmoldt and Alexander M{\"u}ller and Stefanie Iwersen-Bergmann",
year = "2010",
language = "Deutsch",
volume = "200",
pages = "93--99",
journal = "FORENSIC SCI INT",
issn = "0379-0738",
publisher = "Elsevier Ireland Ltd",
number = "1-3",

}

RIS

TY - JOUR

T1 - Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations.

AU - Andresen, Hilke

AU - Sprys, N

AU - Schmoldt, Achim

AU - Müller, Alexander

AU - Iwersen-Bergmann, Stefanie

PY - 2010

Y1 - 2010

N2 - Besides the use of Gamma-Hydroxybutyrate (GHB) as a recreational drug, use of GHB as an agent in drug-facilitated crime should also be considered. In these cases, there is often a delay of several hours from the incident to collection of the samples. As GHB has a very short plasma half-life, the window of detection is small and in the majority of these specimens, levels of GHB are low. Because GHB is naturally occurring in humans, discrimination between endogenous and exogenous GHB is complicated, particularly in those samples with low concentrations. In this study, endogenous GHB levels of 50 serum and 50 urine samples were determined by GC-MS after conversion to trimethyl-silyl-derivatives. Concentrations in serum ranged from 0.62 to 3.24 mg/L (mean=1.14 mg/L; median=0.97 mg/L) and from 0.64 to 4.20mg/L (mean=1.21 mg/L; median=0.96 mg/L) in urine. Based on this substantial data, the current suggested lower cut-off of 4 mg/L in ante mortem serum samples could be confirmed. For urine, we propose the lower cut-off of 6 mg/L instead of 10mg/L to avoid false negative interpretation.

AB - Besides the use of Gamma-Hydroxybutyrate (GHB) as a recreational drug, use of GHB as an agent in drug-facilitated crime should also be considered. In these cases, there is often a delay of several hours from the incident to collection of the samples. As GHB has a very short plasma half-life, the window of detection is small and in the majority of these specimens, levels of GHB are low. Because GHB is naturally occurring in humans, discrimination between endogenous and exogenous GHB is complicated, particularly in those samples with low concentrations. In this study, endogenous GHB levels of 50 serum and 50 urine samples were determined by GC-MS after conversion to trimethyl-silyl-derivatives. Concentrations in serum ranged from 0.62 to 3.24 mg/L (mean=1.14 mg/L; median=0.97 mg/L) and from 0.64 to 4.20mg/L (mean=1.21 mg/L; median=0.96 mg/L) in urine. Based on this substantial data, the current suggested lower cut-off of 4 mg/L in ante mortem serum samples could be confirmed. For urine, we propose the lower cut-off of 6 mg/L instead of 10mg/L to avoid false negative interpretation.

M3 - SCORING: Zeitschriftenaufsatz

VL - 200

SP - 93

EP - 99

JO - FORENSIC SCI INT

JF - FORENSIC SCI INT

SN - 0379-0738

IS - 1-3

M1 - 1-3

ER -